{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:52:36Z","timestamp":1770918756202,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1101836"],"award-info":[{"award-number":["1101836"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1138581"],"award-info":[{"award-number":["1138581"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1149990"],"award-info":[{"award-number":["1149990"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ebiom.2024.105054","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T13:28:47Z","timestamp":1711027727000},"page":"105054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-9331","authenticated-orcid":false,"given":"Kasha P.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-661X","authenticated-orcid":false,"given":"Jennifer M.","family":"Zerbato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Braat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surekha","family":"Tennakoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajantha","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Sasadeusz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Audsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0330-8241","authenticated-orcid":false,"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105054_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105054_bib2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/liv.14059","article-title":"Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection","volume":"39","author":"Tsai","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.ebiom.2024.105054_bib3","doi-asserted-by":"crossref","first-page":"ofaa226","DOI":"10.1093\/ofid\/ofaa226","article-title":"Decreased all-cause and liver-related mortality risk in HIV\/hepatitis B virus coinfection coinciding with the introduction of tenofovir-containing combination antiretroviral therapy","volume":"7","author":"van Welzen","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1468-1293.2012.01051.x","article-title":"Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study","volume":"14","author":"Weber","year":"2013","journal-title":"HIV Med"},{"key":"10.1016\/j.ebiom.2024.105054_bib5","article-title":"Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV\u2013HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study","volume":"20","author":"Boyd","year":"2017","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.ebiom.2024.105054_bib6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/cid\/ciw531","article-title":"Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras","volume":"63","author":"Klein","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105054_bib8","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2024.105054_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/jmv.25360","article-title":"Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection","volume":"91","author":"Malagnino","year":"2019","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ebiom.2024.105054_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/QAD.0b013e328340fde2","article-title":"Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues","volume":"25","author":"Martin-Carbonero","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2024.105054_bib11","doi-asserted-by":"crossref","first-page":"ofw035","DOI":"10.1093\/ofid\/ofw035","article-title":"Liver fibrosis regression measured by transient elastography in human immunodeficiency virus (HIV)-Hepatitis B virus (HBV)-Coinfected individuals on long-term HBV-active combination antiretroviral therapy","volume":"3","author":"Audsley","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cid\/civ421","article-title":"Liver fibrosis by transient elastography and virologic outcomes after introduction of tenofovir in lamivudine-experienced adults with HIV and hepatitis B virus coinfection in Ghana","volume":"61","author":"Stockdale","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/jvh.12658","article-title":"More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections","volume":"24","author":"Ding","year":"2017","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.ebiom.2024.105054_bib14","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/jac\/dkz145","article-title":"Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBV","volume":"74","author":"Grant","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2024.105054_bib15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/cid\/cix122","article-title":"Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia","volume":"64","author":"Vinikoor","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/cid\/civ767","article-title":"More long-term assessment of transient elastography is needed for HIV\/hepatitis B virus-coinfected patients undergoing treatment with tenofovir","volume":"62","author":"Boyd","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib17","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.31823","article-title":"A\u00a0prospective study evaluating changes in histology, clinical and virologic outcomes in HBV-HIV Co-infected adults in North America","volume":"74","author":"Sterling","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2024.105054_bib18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3851\/IMP1649","article-title":"Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use","volume":"15","author":"Boyd","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ebiom.2024.105054_bib19","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1111\/liv.15019","article-title":"Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B","volume":"41","author":"Dezanet","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.ebiom.2024.105054_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2893.2010.01275.x","article-title":"Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV\/HBV-coinfected patients","volume":"18","author":"Miailhes","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.ebiom.2024.105054_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.30825","article-title":"Evaluating noninvasive markers to identify advanced fibrosis by liver biopsy in HBV\/HIV Co-infected adults","volume":"71","author":"Sterling","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2024.105054_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111912","article-title":"Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study","volume":"9","author":"Christiansen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105054_bib23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/infdis\/jiu119","article-title":"Lipopolysaccharide, immune activation, and liver abnormalities in HIV\/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy","volume":"210","author":"Crane","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12601","article-title":"High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair","volume":"280","author":"Bianchi","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ebiom.2024.105054_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008744","article-title":"Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection","volume":"16","author":"Singh","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2024.105054_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104391","article-title":"HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy","volume":"87","author":"Zerbato","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2024.105054_bib27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/1536867X1701700305","article-title":"Model selection for univariable fractional polynomials","volume":"17","author":"Royston","year":"2017","journal-title":"Stata J"},{"key":"10.1016\/j.ebiom.2024.105054_bib28","first-page":"599","article-title":"Natural history, outcome and sustainability of treatment response in chronic viral hepatitis B: Thai multicenter study","volume":"7","author":"Treeprasertsuk","year":"2013","journal-title":"Asian Biomed"},{"key":"10.1016\/j.ebiom.2024.105054_bib29","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.3390\/ijms20215314","article-title":"Role of high-mobility group box-1 in liver pathogenesis","volume":"20","author":"Khambu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2024.105054_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007547","article-title":"Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?","volume":"96","author":"Inkaya","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.ebiom.2024.105054_bib31","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/hep.30093","article-title":"High mobility group box-1 drives fibrosis progression signaling via the receptor for advanced glycation end products in mice","volume":"68","author":"Ge","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2024.105054_bib32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2023.11.005","article-title":"Redox-sensitive high-mobility group box-1 isoforms contribute to liver fibrosis progression and resolution in mice","volume":"80","author":"Ge","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ebiom.2024.105054_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/QAD.0000000000003435","article-title":"Pro-fibrogenic role of alarmin high mobility group box 1 in HIV-hepatitis B virus coinfection","volume":"37","author":"Singh","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2024.105054_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QAD.0b013e3283410ccb","article-title":"Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression","volume":"25","author":"Iser","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2024.105054_bib35","doi-asserted-by":"crossref","first-page":"ofw162","DOI":"10.1093\/ofid\/ofw162","article-title":"Prevalence and outcomes of hepatitis B coinfection and associated liver disease among antiretroviral therapy-naive individuals in a rural Tanzanian human immunodeficiency virus cohort","volume":"3","author":"Ramirez-Mena","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib36","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/651689","article-title":"Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications","volume":"50","author":"Negredo","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib37","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105054_bib38","doi-asserted-by":"crossref","first-page":"ofw060","DOI":"10.1093\/ofid\/ofw060","article-title":"The implications of low absolute CD4 counts in patients with cirrhosis and human immunodeficiency virus","volume":"3","author":"Sullivan","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105054_bib39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2024.105054_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41575-020-0296-6","article-title":"The evolution and clinical impact of hepatitis B virus genome diversity","volume":"17","author":"Revill","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424000896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424000896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T19:03:35Z","timestamp":1738004615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":40,"alternative-id":["S2352396424000896"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105054","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105054"}}